Ciba turns down Biosignal compounds
Wednesday, 06 August, 2008
Global specialty chemical company Ciba Corporation has decided to stop testing Biosignal's [ASX: BOS] anti-microbial industrial compounds, citing major issues incorporating the product into theirs.
Ciba was evaluating whether it could incorporate the compounds into its PVC plastic and coatings, but found that doing so resulted in high temperatures during the processing stage and incompatibility with other components.
Representatives for Biosignal said the decision did not alter expectations for the viability of the compounds, stating that it still had evaluation agreements in place with a number of companies.
These include oil producer ConocoPhillips, sanitation product manufacturers Saraya Co, and leading agrichemicals and animal health companies.
Exclusive colostrum intake may reduce risk of food allergies
Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
Low-dose drug prevents diabetes progression in young people
A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...
